Skip to main content
padlock icon - secure page this page is secure

Open Access Left Ventricular Dysfunction in Ischemic Heart Disease

Download Article:
 Download
(HTML 52.8 kb)
 
or
 Download
(PDF 123.3 kb)
 

This article is Open Access under the terms of the Creative Commons CC BY-NC licence.

Ischemic heart disease is a growing cause of heart failure owing to the increasing prevalence of diabetes, hypertension, and obesity. It is important to understand the concepts of myocardial stunning and hibernation so we as physicians can order appropriate testing on patients with ischemic heart disease, such as myocardial viability studies. Ventricular remodeling is associated with an elevated risk of death after myocardial infarction. The extent of myocardial viability determines the clinical outcome of patients after myocardial infarction. Multiple impactful clinical trials have changed the way we manage ischemic cardiomyopathy over the past few decades, and medications such as angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta-blockers, and aldosterone antagonists have improved outcomes in this patient population. Similarly, much has been reported on the effect of coronary artery bypass surgery on outcomes in patients with ischemic heart disease and heart failure, but further research studies are needed on the role of percutaneous coronary intervention.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: heart failure; ischemic cardiomyopathy; ischemic heart disease; viability

Document Type: Research Article

Publication date: January 1, 2019

This article was made available online on January 16, 2019 as a Fast Track article with title: "Left Ventricular Dysfunction in Ischemic Heart Disease".

More about this publication?
  • Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Membership Information
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more